|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.19 USD | -5.94% |
|
-0.65% | -46.10% |
| May. 07 | Neumora Therapeutics Shares Fall as Q1 Loss Narrows | MT |
| May. 07 | Neumora Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
April 15 (Reuters) - Neumora Therapeutics said on Monday the U.S. Food and Drug Administration had placed a clinical hold on early-stage study of its experimental schizophrenia drug. (Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
| 1st Jan change | Capi. | |
|---|---|---|
| -46.10% | 1.47B | |
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| +46.56% | 41.85B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
NEUMORA THERAPEUTICS, INC. 